Award recordCONTRACT

EMERGENT DEVICES, INC.

PIID 36C77018N1036· VHA· NATIONAL CMOP OFFICE (36C770)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $857,451 net obligations· UEI Q1MZNNSQUJ53· PA

Description

NALOXONE HCL 4MG/SPRAY SOLN,SPRAY,NASAL

First action · last action
2018-08-02 · 2018-10-26
Transactions
2
First transaction's obligation
$858,000
Base + all options value (sum of deltas)
$857,451
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70052
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$858,000$0Base award · 2018-08-02 · this action $858,000 · running total $858,000Modification P00001 · 2018-10-26 · this action -$549 · running total $857,451
  • Base2018-08-02+$858,000= $858,000
  • Mod P000012018-10-26-$549= $857,451
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-08-02+$858,000$858,000NALOXONE HCL 4MG/SPRAY SOLN,SPRAY,NASAL
Mod P00001· FUNDING ONLY ACTION2018-10-26−$549$857,451NALOXONE HCL 4MG/SPRAY SOLN,SPRAY,NASAL

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI Q1MZNNSQUJ53)

AwardOffice · PSC / listingNet obligationsFY
36F79723D0188NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C77023N0087NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C77023N0062NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$542,736FY2023
36C77022P0206NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$665,184FY2022
36C77022N0074NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$665,184FY2022
36C77022N0065NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$665,184FY2022

Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C77026P0118HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$30,935FY2026
36C77026P0129DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$76,656FY2026
36C77026P0127DERRAH MORRISON ENTERPRISES LLCNATIONAL CMOP OFFICE (36C770)$58,395FY2026
36C77026P0086SAGENT PHARMACEUTICALS, INCNATIONAL CMOP OFFICE (36C770)$275,580FY2026
36C77026P0095HYGEN PHARMACEUTICALS INCNATIONAL CMOP OFFICE (36C770)$83,520FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77018N1036_3600_V797D70052_3600 · retrieved 2026-09-26.